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a b s t r a c t
The transcription factor STAT5 mediates prolactin signaling and controls functional development of
mammary tissue during pregnancy. This study has identiﬁed the miR-193b locus, also encoding miRNAs
365-1 and 6365, as a STAT5 target in mammary epithelium. While the locus was characterized by active
histone marks in mammary tissue, STAT5 binding and expression during pregnancy, it was silent in most
non-mammary cells. Inactivation of the miR-193b locus in mice resulted in elevated mammary stem/
progenitor cell activity as judged by limiting dilution transplantation experiments of primary mammary
epithelial cells. Colonies formed by mutant cells were larger and contained more Ki-67 positive cells.
Differentiation of mammary epithelium lacking the miR-193b locus was accelerated during puberty and
pregnancy, which coincided with the loss of Cav3 and elevated levels of Elf5. Normal colony
development was partially obtained upon ectopically expressing Cav3 or upon siRNA-mediated
reduction of Elf5 in miR-193b-null primary mammary epithelial cells. This study reveals a previously
unknown link between the mammary-deﬁning transcription factor STAT5 and a microRNA cluster in
controlling mammary epithelial differentiation and the activity of mammary stem and progenitor cells.
Published by Elsevier Inc.
Introduction
Cytokines control a large panel of biological functions, many of
them mediated by the JAK-STAT signal transduction pathway. The
transcription factors Signal Transducer and Activator of Transcription
5A and 5B (collectively referred to as STAT5) are executors of such
cytokines as prolactin, growth hormone, erythropoietin, and inter-
leukins (Hennighausen and Robinson, 2008). In mammary tissue
STAT5 is required for the establishment and maintenance of alveolar
progenitors during puberty (Yamaji et al., 2009) as well as for
alveolar proliferation and differentiation during pregnancy (Cui
et al., 2004; Liu et al., 1997; Miyoshi et al., 2001). STAT5-regulated
genes encode transcription factors, membrane proteins, enzymes and
milk proteins (Hennighausen and Robinson, 2005). Concentration-
dependent and stage-speciﬁc STAT5 binding to respective regulatory
elements ensures the temporally coordinated activation of genetic
programs (Kang et al., 2014; Yamaji et al., 2013).
In addition to controlling cell differentiation, STAT5 also impacts
the biology of stem cells. STAT5-deﬁcient HSCs are unable to
compete with wild type cells in bone marrow transplantation
assays and conditional ablation of STAT5 from adult HSCs in the
mouse causes loss of quiescence and a rapid depletion of the long
term repopulating stem cell pool (Wang et al., 2009). In contrast,
transplantation experiments with primary mammary epithelial
cells have not provided evidence for a role of STAT5 in mammary
stem cells (Yamaji et al., 2009).
Cytokines, and their executive transcription factors, are con-
sidered modulators of biological programs rather than master
regulators. MicroRNAs have also been implicated in ﬁne-tuning
physiological parameters. Evidence is building that cytokines,
through STAT transcription factors, also control the expression of
speciﬁc microRNA genes. STAT3 and STAT5 have been implicated
in the activation of the loci encoding miR-21, miR-15/16 (Li et al.,
2010) and miR‐1792 (Feuermann et al., 2012). Although numer-
ous studies have alluded to roles of miRNAs in breast cancer cell
lines, their contribution to the development and function of
mammary epithelium in mice is likely more subtle (Feuermann
et al., 2014; Feuermann et al., 2012). Based on in vitro studies using
cultured primary cells a role of miR-146b in alveolar differentia-
tion has been proposed (Elsarraj et al., 2012). While it is assumed
that miRNAs in general target cell autonomously the stromal
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/developmentalbiology
Developmental Biology
http://dx.doi.org/10.1016/j.ydbio.2014.09.012
0012-1606/Published by Elsevier Inc.
n Correspondence to: NIDDK/NIH, Building 8, Room 101 Bethesda, MD 20892,
USA.
E-mail address: lotharh@mail.nih.gov (L. Hennighausen).
1 KHY, KK and YF contributed equally to this study.
2 GWR and LH are joint senior authors.
Developmental Biology 395 (2014) 245–254
presence of miR-212 was reported to be required for mammary
epithelial development in mice (Ucar et al., 2010). However, a role
for miR-212 in mammary development and function has been
disputed (Kayo et al., 2014; Remenyi et al., 2013).
This study focused on the identiﬁcation and biological under-
standing of miRNA loci in mammary tissue that are under control of
the cytokine-induced transcription factor STAT5. Several years ago our
lab has identiﬁed miR-193b as a cytokine-inducible miRNA in primary
mammary and hematopoietic cells and we investigated its role in the
development and physiology of brown adipose tissue (Feuermann
et al., 2013; Sun et al., 2011). Now these studies were extended to
mammary tissue and ChIP-seq analyses were used to identify addi-
tional miRNA loci under STAT5 control in mammary tissue. In
addition we have used mouse genetics to explore the function of
the miR-193b-365-1 locus in mammary epithelium and stem cells.
Results
The miR-193b locus is under STAT5 control
MicroRNA loci under STAT5 control were identiﬁed using
ChIP-seq data sets for STAT5, progesterone receptor (PR), NFIB,
H3K4me3 and H3K4me2 (Chang et al., 2013; Kang et al., 2014; Lain
et al., 2013; Lemay et al., 2013; Rijnkels et al., 2013; Yamaji et al.,
2013) and RNA-seq from wild type and Stat5-null mammary
tissue. Histone marks characteristic of active promoters
(H3K4me3) and enhancers (H3K4me2) and binding of transcrip-
tion factors serve as indicators of transcribed loci. The loci
encoding miR-193b, miR-146b and miR-148a fulﬁlled the deﬁning
criteria, i.e., binding of STAT5 and PR to putative regulatory
sequences, the presence of H3K4me3 and H3K4me2 marks and
STAT5-dependent transcription (Fig. 1A). While the miR-146a locus
is also a bona ﬁde STAT3 target in breast cancer cells (Xiang et al.,
2014) and miR-146b controls mammary cell differentiation in vitro
(Elsarraj et al., 2013), no pertinent information exists on the roles
of the miR-148a and miR-193b loci in mammary development.
MiR-193b is unique in that it is expressed signiﬁcantly only in
a few cell types, mammary epithelium, brown adipose tissue
(Feuermann et al., 2013; Sun et al., 2011) and hematopoietic
progenitor cells (Kuchen et al., 2010). The miR-193b locus is
transcribed as poly (Aþ) transcripts and also encodes miR-365-1
and miR-6365 (Fig. 1B). H3K4me3 and H3K4me2 marks were
identiﬁed over putative promoter and regulatory sequences in
mammary epithelium. H3K27me3 levels spanning the locus were
low and H3K36me3 marks covered the transcribed region, in
agreement with an active gene locus (Fig. 1B). In contrast, in liver
tissue the locus was not bound by STAT5, displayed high
H3K27me3 levels and there was a paucity of H3K36me3 marks
(Fig. 1B). STAT5-dependent expression of the miR-193b locus,
Fig. 1. Features of the miR-193b locus. (A) Integrative analysis of available ChIP-seq data (Chang et al., 2013; Kang et al., 2014; Lain et al., 2013; Lemay et al., 2013; Rijnkels et al.,
2013; Yamaji et al., 2013) revealed regulatory regions (gray bars) at themiR-146b,miR-148a andmiR-193b loci. HFSC, hair follicle stem cells; PR, prolactin receptor; MG, mammary
gland; NFIB motif, TGGCC and STAT5 motif, TTCnnnGAA. (B) Analysis of RNA-seq and available histone ChIP-seq data reveals an activemiR-193b locus in mammary tissue while it
is silent in liver. Gray bar indicates putative transcription start site of the miR-193b transcript as described previously (Feuermann et al., 2013). MiR-193b was the ﬁrst STAT5-
regulated miRNA identiﬁed in this lab and the respective locus was inactivated in the mouse prior to the identiﬁcation of the STAT5-controlled miR-146 and miR-148a.
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as well as other miRNA loci, was interrogated with RNA-seq in
mammary tissue at day 6 of pregnancy (p6) (Supplementary
Table 1). Wild type mammary tissue, carrying both Stat5a and both
Stat5b alleles, was compared with mutant tissue carrying only one
Stat5b allele, which amounts to approximately 10% of total STAT5
levels (Yamaji et al., 2013). In contrast to a complete absence of
STAT5, which inhibits alveologenesis, these low levels of STAT5 are
sufﬁcient for the formation of immature alveoli (Yamaji et al., 2013).
Levels of miR-193b in control and mutant tissues were 5.6 and
1.7 FPKM, respectively (Supplementary Table 1), demonstrating that
this locus is actively controlled by STAT5.
Increased stem and progenitor cell activity in the absence
of the miR-193b locus
MiR-193b was the ﬁrst STAT5-regulated miRNA identiﬁed and the
respective locus was inactivated in the mouse prior to the identiﬁca-
tion of the STAT5-controlled miR-146 and miR-148a. The miR-193b
locus has been inactivated through the removal of a 4 kb fragment
spanning promoter and regulatory sequences and the entire coding
region of miR-193b (Feuermann et al., 2013). RNA-seq analyses from
control mammary tissue at day 13 of pregnancy (p13) demons-
trated the presence of transcripts spanning the entire locus (Fig. 1B).
Fig. 2. Increased stem cell activity in the absence of themiR-193b locus. (A) FACS analysis of mammary epithelium from 8 to 12 week-old nulliparous mice (wild type on left).
(B) Graph showing MEC population from three wild type and three mutant mice. (C) Representative images of wholemounts of repopulated fat pads injected with the
indicated numbers of MECs. (D) Ratio of the number of repopulated fat pads per number of fat pads injected with 1000, 200 and 100 MECs, respectively.
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No transcripts were seen in miR-193b / mammary tissue, validating
that this locus has been fully inactivated.
FACS analyses did not reveal overt differences between primary
mammary epithelial cells (MECs) isolated from wild type and
miR-193b / tissue of nulliparous mice at 12 weeks of age
(Luminal; 16.2675.93 vs 14.6472.46%, Basal; 49.52710.58 vs
50.1575.92%, MaSCs; 10.0774.60 vs 8.4372.45% in miR-193b /
and control, respectively) (Fig. 2A and B). Although the different cell
populations, based on surface markers, were equivalent inwild type
and mutant mice, limiting dilution transplantation experiments
were used to determine their functional capacity. Decreasing
numbers of primary mammary epithelial MECs were transplanted
into cleared fat pads of recipient mice and ductal outgrowth was
monitored after four weeks (Fig. 2C). Upon implanting 1000 cells,
60% of wild type and 80% of mutant transplants formed a ductal
tree. Upon transplanting 200 cells, only 33% of the wild type
transplants but 80% of the mutants formed ducts. When 100 wild
type cells were transplanted into each of 18 hosts, ductal out-
growth, albeit very small, was observed in only two mice. In
contrast, more extended ductal outgrowth was observed in 10 out
of the 18 hosts that had been injected with 100 mutant cells (Fig. 2C
and D). ELDA analysis (Hu and Smyth, 2009) estimated the repopu-
lating frequency for wild type cells at 1/950 (1/580 to 1/1570). For
mutant cells the frequency was 1/300 (1/200-201/500) with a
p value of 0.0004. The divergent results of these two assays (FACS
vs transplantation) suggest that the presence of speciﬁc epitopes
might characterize speciﬁc cell populations but not their complete
biological activity.
Next we gauged the proliferative capacity of alveolar cells in a
deﬁned in vitro setting by mammary colony formation assays.
Fig. 3. Enhanced progenitor cell activity in the absence of miR-193b (A) Pictures were taken at days 0 and 7 after placing primary MECs in a colony formation culture system
(Scale bar: 50 μm). (B) Representative pictures of colonies stained with crystal violet at day 10. (C) Graphs with the number and size of colonies. Three biological replicates
were analyzed. (D) Confocal images of colonies stained for E-cadherin (Green), α-SMA (Green) and ZO-1 (Red) at day 7 and Ki-67 (Red), pH3 (Red) and K14 (Red) at day
4 with DAPI (Blue) as a counterstain (Scale bar: 20 μm). (E) Graphs with the number of positive cells stained with Ki-67 and pH3.
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Primary MECs isolated from 8–12 weeks old miR-193b / and
wild type nulliparous females were cultured and the formation of
colonies was analyzed over a period of 10 days (Fig. 3A and B).
Reproducibly miR-193b / MECs had an approximately 20%
reduced capacity to form colonies (Fig. 3C). However, the size of
colonies established from mutant MECs (58.878.8 μm) was
approximately 50% bigger than that of controls (39.574.2 μm)
(Fig. 3A–C). Immunoﬂuorescence staining for Cdh1 (E-cadherin)
and Acta2 (a-SMA) veriﬁed the presence of a single epithelial
layer and attached basal cells that were further characterized by
the presence of Keratin 14 (K14) (Fig. 3D). Correctly located TJP1
(ZO-1) demonstrated the presence of polarized epithelium.
Whole mount nuclear staining with DAPI revealed an increased
number of epithelial cells in miR-193b / colonies (Fig. 3D). To
compare the extent of proliferation in the presence and absence of
miR-193b, colonies were stained with two different proliferation
markers, Ki-67 and phosphorylated histoneH3 (pH3) after 4 days
in culture (Fig. 3D). MiR-193b / colonies were enlarged and had
more cells positive for Ki-67 (miR-193b /: 15.8074.55, control:
8.0072.10) and pH3 (miR-193b /: 11.2075.02, control: 5.607
2.41) (Fig. 3E). These ﬁndings show increased proliferation of
preferentially luminal cells in the absence of the miR-193b locus.
Precocious differentiation of mammary epithelium in the absence
of the miR-193b locus
Proliferation and differentiation of mammary epithelium dur-
ing pregnancy are tightly coupled and regulated processes. Mam-
mary tissue from nulliparous mice (Fig. 4) was analyzed to
determine a potential contribution of miR-193b in epithelial
differentiation. Histologically, alveolar and ductal structures from
non-parous wild type and mutant mice were indistinguishable
(Fig. 4A and B). However, reduced expression of Slc12a2 (Nkcc1) in
luminal cells from mutant mice was a harbinger of an accelerated
differentiation program in the absence of the miR-193b locus
(Fig. 4C–F). At p13, the histological appearance of emerging alveoli
in miR-193b / mice supported the presence of a precocious
differentiation program (Fig. 5). The number of cross-sectioned
alveoli/mm2 was determined in 10 randomly selected ﬁelds from
3 mice in each group and a signiﬁcant increase was observed in
the absence of miR-193b (148/mm271.8 in controls vs 198/
mm274.4 in miR-193b/: p¼0.0002). While alveoli in control
mice displayed the typical undifferentiated appearance, signs of
secretory differentiation such as fat globules were already visible
in mutant epithelia.
Fig. 4. Reduced NKCC1 in ductal epithelium in the absence of the miR-193b locus H&E staining of histological sections from mammary tissue from control (A) and miR-193b
mutant (B) nulliparous mice. Immunoﬂuorescence for NKCC1 (red) and a-SMA (green) in control (C, E) and mutant (D, F) tissues. Arrows point to luminal cells that
express NKCC1.
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RNA-seq analyses were performed to evaluate the degree of
differentiation of normal and mutant mammary epithelium at p13.
Clustering analysis based on the expression of all genes revealed a
marked difference between normal and mutant mammary epithe-
lium (Fig. 6A). Expression of approximately 450 genes was induced
signiﬁcantly in the absence of the miR-193b locus and expression
of approximately 500 genes was reduced by more than 50% (Fig. 6,
Supplementary Table 2). One half of the upregulated genes were
genuine STAT5 targets, mainly associated with the process of
lactation, including transporter membrane proteins and milk
proteins, such as Wap and Csn1s2b (Fig. 6C). Several genes know
to control alveolar differentiation were deregulated in the absence
of miR-193b. Cav3 was expressed at 9 FPKM in control tissue and
was reduced by 90% in the absence of miR-193b. Elf5 was
expressed at 234 FPKM in controls and levels increased 1.8-fold
in mutant tissue (Supplementary Table 2). Expression of Cidea, a
transcriptional co-regulator controlling mammary function (Wang
et al., 2012) was elevated four-fold in mutant tissue. Moreover,
expression of several dual speciﬁc phosphatases was reduced in
mutant tissue.
Precocious mammary epithelial differentiation has been observed
upon loss of Caveolin-3 (Sotgia et al., 2009) or tyrosine phosphatase
PTP1B (Milani et al., 2013), inappropriate activation of STAT5 (Dong
et al., 2010; Vafaizadeh et al., 2010) or overexpression of ELF5 (Oakes
et al., 2008). To determine whether deregulated expression of Cav3
and Elf5 in the absence of miR-193b could be causal to the observed
biology, we tested their functional role in vitro (Fig. 7). Short interfering
RNAs (siRNAs) were used to reduce ELF5 levels in miR-193b / MECs
and separately Cav3was overexpressed. Subsequently these cells were
cultured in matrigel for 6 days to evaluate the effect of altering the
expression of these potential targets on colony behavior. Expression
of Elf5 and Cav3 in control and mutant cells was established by real-
time qPCR. Elf5 expression in miR-193b / cells (3.1370.36) was
3-fold higher compared to controls (1.0070.31). In the presence of
Elf5-siRNAs, its expression was signiﬁcantly reduced in miR-193b /
(1.1570.63). Whole mount assay validated that the absence of
miR-193b resulted in larger colonies as had already been shown in
an earlier experiment (Fig. 3). Knock-down of Elf5 reduced colony size
(control: 28.1878.95, miR-193b /: 63.5679.49, miR-193b / trea-
ted with Elf5 siRNAs: 48.1779.14 mm). Cav3 expressionwas 40% lower
Fig. 5. Precocious differentiation of mammary epithelial activity in the absence of themiR-193b locus Low (A and B) and high (C and D) magniﬁcation images of hematoxylin
and eosin stained sections of p13 mammary tissues show increased alveolar development and accelerated differentiation in mutant (A and C) compared to controls (B and D).
Arrows point to alveoli.
Fig. 6. Identiﬁcation of differentially expressed genes in the absence of miR-193b (A) Clustering analysis of RNA-seq result reveals a marked difference of gene expression
betweenwild-type and mutant mammary tissues obtained at p13. Three biological replicates were used. (B) Percentage of STAT5-dependent genes among 456 induced genes
is shown. (C) Expression levels of Stat5a, Stat5b, Wap and Csn1s2b are shown. *FDR-adjusted p value o0.05.
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in miR-193b / cells (0.6070.16) compared to controls (1.0070.11)
and expression was restored in Cav3-overexpressing cells
(1.0470.02). Overexpression of Cav3 in miR-193b/ MECs (control:
20.8374.36,miR-193b/: 50.2876.70,miR-193b/ overexpressing
Cav3: 35.8178.87 mm) resulted in colonies with an intermediate size.
These results indicate that miR-193b controls mammary epithelial
proliferation and differentiation in part through regulating expression
of Elf5 and Cav3.
Discussion
Since the miR-193b locus, encoding also miR365-1 and miR-6365,
is under STAT5 control, its loss could affect functions attributed to
STAT5. Notably, enhanced in vivo activity of MaSCs in the absence of
the miR-193b locus resembled accelerated cycling of HSCs lacking
STAT5 (Wang et al., 2009). However, loss of STAT5 in mammary stem
cells has no overt consequences on their repopulation capacity
(Yamaji et al., 2009) suggesting also STAT5-independent functions
of themiR-193b locus. It is not clear whether any of the three miRNAs
in this locus control MaSC activity by themselves or in combination
with each other. While several studies have shown that speciﬁc
genes, such as Lgr5 (Plaks et al., 2013), Fak (Luo et al., 2013) and Ezh2
(Pal et al., 2013) positively control MaSC activity (Fu et al., 2014), the
miR-193b locus restricts MaSC activity in vivo and the proliferative
capacity of progenitor cells.
Development and differentiation of mammary epithelium in
non-parous mice and in early pregnancy is enhanced in the
absence of the miR-193b locus, which coincides with larger sized
colonies derived from primary MECs, indicative of a role in
coordinating mammary alveolar differentiation. Execution of tem-
poral differentiation programs can be controlled at different levels,
mainly through the expression of positive and negative regulators
and the activation of STAT5. Loss of the miR-193b locus resulted in
elevated levels of the mammary transcription factor ELF5 and the
reduction of Caveolin-3, suggesting that their respective deregula-
tion was, at least in part, responsible for the altered biology of
mutant tissue. This notion was supported as partial correction of
Elf5 and Cav3 expression in miR-193b / cells alleviated the
effects on colony growth in vitro. Consistent with these ﬁndings,
the phenotypes of transgenic mice overexpressing ELF5 (Oakes
et al., 2008) and those of Cav3 gene knock-out mice (Sotgia et al.,
2009) mimic the precocious differentiation observed in the
absence of the miR-193b locus. It is likely that precocious differ-
entiation is the result of the deregulation of several genes, possibly
also including those encoding dual speciﬁc phosphatases.
Differentiation of mammary epithelium is not only controlled
cell intrinsically but also responds to cues from the embedding
stroma. While this study demonstrated a cell-autonomous role for
the miR-193b locus in the epithelial compartment, other miRNAs
are likely to control mammary development through stromal cells
in a paracrine fashion. Notably, the presence of miR-212 in the
stromal compartment of mammary tissue is required for mam-
mary epithelial development (Ucar et al., 2010) although these
ﬁndings have been questioned (Kayo et al., 2014; Remenyi et al.,
2013). A study (Llobet-Navas et al., 2014) described a key role of
the miR-424 cluster in orchestrating remodeling of mammary
tissue during involution, highlighting the contributions of miRNAs
in modulating biological programs.
Extensive literature has been published on the potential role
of miRNAs in breast cancer cell lines but there is a paucity of
in vivo studies. Studies with primary cells have demonstrated that
miR-146b, a known STAT3 target (Xiang et al., 2014), promotes
alveolar progenitor cells in a cell line-based organ culture system
Fig. 7. Identiﬁcation of functional roles of ELF5 and caveolin3 in miR-193b/ cultures (A) Colonies generated by miR-193b / MECs treated with Elf5-siRNAs. (B) Colonies
generated by miR-193b/ MECs with restored Cav3 expression. Whole mount assay (top, original magniﬁcation; 5) and representative pictures of colonies (lower, scale
bar: 50 μm) at day 6. Quantitative real-time qPCR analysis of Elf5 and Cav3 (left). Graph with the size of colonies (right).
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(Elsarraj et al., 2013). STAT5 and PR are also binding to respective
regulatory sequences in this locus further supporting the notion
that miR-146b executes hormone function in mammary epithe-
lium. MiR-22 and miR-205 are enriched in mammary progenitor
cells (Ibarra et al., 2007) but an in vivo role has not been
investigated. Based on ChIP-seq data from this lab and others
(Lain et al., 2013) both these loci are recognized by STAT5 and PR
supporting a role in the physiology of the mammary gland.
Although computational approaches have been used to predict
miRNA targets, gene expression proﬁling from miRNA knock-out
tissues have failed to reliably validate proposed targets (Feuermann
et al., 2012, 2013, 2014). Similarly, the genes deregulated in
mammary tissue lacking the miR-193b locus are not predicted
targets of miR-193b, miR-365-1 and miR-6365. However, transcrip-
tional analyses of mutant tissue led to the identiﬁcation of tran-
scripts, including Elf5 and Cav3, whose altered levels can account
for the observed phenotypes as demonstrated in this study (Fig. 8).
Notably, ELF5 also controls the activity of mammary stem and
progenitor cells (Oakes et al., 2008) and Caveolin-3 is a negative
regulator of alveolar differentiation (Sotgia et al., 2009). This study,
for the ﬁrst time, demonstrates an intersection between miRNAs
and cytokine-STAT5-mediated developmental programs in mam-
mary epithelium. It remains an open question whether the miR-
193b locus asserts its biology through targeting speciﬁc develop-
mental genes or through a yet to be determined mechanism.
Materials and methods
Mice and transplantation of primary mammary epithelial cells
Mice with a targeted miR-193b locus have been described
(Feuermann et al., 2013). Mammary tissue from nulliparous mice
was chopped and digested at 37 1C, shaking at 200 rpm for 2 h in
complete EpiCult-B medium (EpiCult-B medium with 5% fetal
bovine serum, 10 ng/mL recombinant human epidermal growth
factor, 10 ng/mL recombinant human basic ﬁbroblast growth
factor, 0.0004% heparin) supplemented with 300 U/mL collagenase
100 U/mL hyaluronidase. After lysis of red blood cells in NH4Cl, a
single-cell suspension was obtained by sequential dissociation of
the fragments with pre-warmed 0.25% trypsin-EDTA for 1–2 min,
followed by pre-warmed 5 mg/mL dispase II plus 0.1 mg/mL
DNase I (DNase; Sigma) for 2 min, and ﬁltration through a
70-μm mesh. All reagents were from StemCell Technologies, Inc.
unless otherwise speciﬁed. Deﬁned numbers of isolated MECs
were injected into the cleared fat pads of immunocompromised
hosts (nu/nu athymic). Four weeks later the transplants were
harvested and outgrowths were evaluated on carmine stained
whole mounts. Stem cell frequencies were determined by ELDA
(Hu and Smyth, 2009).
MECs preparation and FACS analysis
Mammary epithelial cells (MECs) were isolated using a stan-
dard protocol and non-epithelial cells were removed using the
EasySep™ Mouse Mammary Stem Cell Enrichment Kit (STEMCELL
TECHNOLOGY, #19757). MECs were stained with biotinylated anti-
CD24-ﬂuorescein isothiocyanate (FITC, BD Biosciences), anti-
CD49f-R-phycoerythrin (R-PE, BD Biosciences) and 7-amino-
actinomycin D (7AAD, BD Biosciences). FACS analysis was per-
formed using FACSAria (BD Biosciences). Only live cells were gated
from the 7AAD negative portion and FACS analysis of the CD49f
and CD24 cell population in mammary epithelial cells yielded four
different cell populations: negative (CD24CD49f), luminal
(CD24hiCD49f lo) and basal (CD24þCD49f hi) cells. The latter ones
were divided into two different populations: myoepithelial
(CD24loCD49f hi) and the stem cell-enriched (CD24midCD49f hi).
Our analysis and interpretation of the data are based on deﬁned
epitope distribution used by others (Shackleton et al., 2006; Stingl
et al., 2006) and our lab (Yamaji et al., 2009).
Colony formation assays
106 MECs from 8 to 14 week-old virgin mice were plated
overnight on ultra-low attachment plates (Corning) with monolayer
media (DMEM/F12, 5% FBS, 1% Pen/Strep, 1X Insulin-Transferrin-
Selenium-X Supplement (ITS-X), 1 μg/ml hydrocortisone and 10 ng/
ml EGF) at 37 1C to allow formation of aggregates. 200 aggregates
were plated in GFR-matrigel with naked media (DMEM/F12, 1% Pen/
Strep and 1X ITS-X) and incubated at 37 1C for 20 min to let the
mixture gel. Aggregates in GFR-matrigel were cultured with EGF
media (DMEM/F12, 1% Pen/Strep, 1X ITS-X, 10 ng/ml EGF and
0.0004% heparin), which was changed every 48 h.
RNA-seq analysis
RNA-seq was performed with total RNAs extracted from mam-
mary gland tissues of wild type (miR-193bþ /þ) and mice lacking the
miR-193b locus (miR-193b/) at day 13 of pregnancy (p13). Analysis
was performed as described previously (Feuermann et al., 2013).
Histology and immunostaining
Tissues were ﬁxed in formalin and processed for parafﬁn
embedding and hematoxylin and eosin staining by standard
procedures. For immunostaining deparafﬁnized 5 μm sections
were treated in a Biocare Decloaker. Anti-NKCC1 (1:1000; gener-
ous gift from Dr. J. Turner, NIDCR, NIH) and smooth muscle actin
(1:1000; Sigma) were applied after blocking with 3% goat serum.
Secondary antibodies (1:400) were conjugated with Alexaﬂuor
488 and 594, respectively. Images were captured with a Retiga EXi
camera and processed with Image-Pro Plus software.
Fig. 8. Proposed model linking the miR-193b locus to the biology of mammary
stem cells and differentiating epithelium. The miR-193b locus is under STAT5
control and negatively controls the activity of mammary stem and progenitor cells.
This conclusion is based on mouse genetics, where loss of miR-193b resulted in
enhanced stem and progenitor cell activity. Loss of miR-193b also resulted in
precocious differentiation of mammary epithelium during pregnancy and a con-
comitant induction of Elf5 expression and reduced Cav3 expression. The functional
contribution of ELF5 and caveolin3 in mammary alveolar differentiation was
determined in in vivo loss-of-function and gain-of-function studies using colony
formation assays in this research.
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Colony formation cultures were ﬁxed with 2% paraformalde-
hyde for 20 min at RT and permeabilized with 0.5% TritonX-100 in
PBS for 10 min at 4 1C. Rins them three times with 100 mM glycine
in PBS and blocked with 10% FBS in IF buffer (NaN3 7.7 mM. 0.1%
BSA, 0.2% TritonX-100, 0.05% Tween20) for 1 h at RT then incubate
with the indicated antibodies diluted in blocking buffer overnight
at 4 1C. Antibodies used were: anti-E-cadherin (BD Biosciences,
610182), anti-aSMA (Sigma, A2547), anti-ZO-1 (Miyoshi et al.,
2001), anti-Ki67 (abcam, ab16667), anti-pH3 (millipore, 06–570)
and anti-K14 (Covance, PRB-155p). After washing three times with
IF buffer, incubate with secondary antibodies Alexa 594 goat anti-
rabbit (Life technologies, A11037) and Alexa 488 anti-mouse
(Life technologies, A11029) and DAPI (Sigma, D9564) were applied
for 45 min at RT. The preparations were analyzed with a LSM700
Zeiss confocal microscope.
siRNA treatment and transient transfection assay
For knockdown experiments, siRNA targeting the Elf5 gene
(ON-TARGETplus Elf5 siRNA, J-044985-12) and GFP Duplex I siRNA
(P-002048-01-20) as positive control were purchased from Dharma-
con. siRNA transfection were conducted using Lipofectamine RNAi-
MAX (Invitrogen, 13778-075). For overexpression experiments, cDNA
clone for Cav3 (MR226246) and pCMV6-Entry vector (PS100001) as
positive control were purchase from OriGene. MECs were transfected
using FuGene HD Transfection Reagent (Promega, E2311).
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